IQVIA Holdings Inc. (IQV) vs Medline Inc. (MDLN)

A side-by-side comparison of IQVIA Holdings Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnIQV vs MDLN

growth of $100 · dividends reinvested · last 1y
IQV -6.4%MDLN -3.2%MDLN compounded faster
708090100110120Start $1002026$94$97
IQV MDLN

IQV vs MDLN: by the numbers

  • IQV is the larger company ($40.61B vs $34.26B market cap).
  • IQV trades at the lower trailing earnings multiple (26.42 vs 32.81 P/E), one valuation lens rather than an overall verdict.
  • IQV converts more revenue to profit (8.10% vs 3.31% net margin).

Metrics side by side

Valuation

MetricIQVMDLN
P/E ratio26.4232.81
Forward P/E16.6426.21
P/S ratio2.181.12
P/B ratio5.822.91
PEG ratio6.34N/A
EV / EBITDA14.4914.47
FCF yield7.03%4.66%

Profitability

MetricIQVMDLN
Gross margin26.23%24.04%
Operating margin13.57%7.04%
Net margin8.10%3.31%
ROE22.28%8.55%
ROIC8.23%5.69%

Growth (annualized)

MetricIQVMDLN
Revenue CAGR (5Y)5.61%N/A
EPS CAGR (5Y)40.21%N/A
FCF CAGR (5Y)6.92%N/A
Total return CAGR (5Y)-0.17%N/A

Frequently asked

Which has the lower trailing P/E, IQV or MDLN?
IQV has the lower trailing P/E: IQV trades at 26.42 and MDLN at 32.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is IQV or MDLN more profitable?
IQV runs the higher net margin — IQV at 8.10% versus MDLN at 3.31%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.